2) The Company exited its investment in InstantScripts after shareholders accepted the sale of the company to Australian Pharmaceutical Industries Pty Ltd, a wholly owned subsidiary of Wesfarmers Limited. The transaction has resulted in BTI expected to realise $52 million cash from the transaction. The sale price represented a 25% increase in the carrying value of the investment.